Atara Biotherapeutics (STU:AT2) Research & Development : €192.47 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Atara Biotherapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Atara Biotherapeutics's Research & Development for the three months ended in Mar. 2024 was €41.87 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €192.47 Mil.

Atara Biotherapeutics Research & Development Historical Data

The historical data trend for Atara Biotherapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Research & Development Chart

Atara Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

194.49

201.10

249.57

257.27

206.13

Atara Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															58.05	51.82	53.30	45.48	41.87

Atara Biotherapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €192.47 Mil.

Atara Biotherapeutics (STU:AT2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Atara Biotherapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Atara Biotherapeutics (STU:AT2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (STU:AT2) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT2:Germany

Address

2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (STU:AT2) Headlines

No Headlines